RCAR (RenovaCare) Total Liabilities: $2.52 Mil (As of Sep. 2022)


What is RenovaCare Total Liabilities?

RenovaCare RCAR -99.00% Total Liabilities is $2.52 Mil as of Sep. 2022.

RenovaCare's Total Liabilities for the quarter that ended in Sep. 2022 was $2.52 Mil.

RenovaCare's quarterly Total Liabilities increased from Mar. 2022 ($2.19 Mil) to Jun. 2022 ($2.69 Mil) but then declined from Jun. 2022 ($2.69 Mil) to Sep. 2022 ($2.52 Mil).

RenovaCare's annual Total Liabilities increased from Dec. 2019 ($0.28 Mil) to Dec. 2020 ($1.32 Mil) but then declined from Dec. 2020 ($1.32 Mil) to Dec. 2021 ($1.31 Mil).

RenovaCare Total Liabilities Historical Data

* Premium members only.

The historical data trend for RenovaCare's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RenovaCare Total Liabilities Chart

RenovaCare Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 0.39 0.28 1.32 1.31

RenovaCare Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 1.31 2.19 2.69 2.52

RenovaCare Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RenovaCare's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.305+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.31

Total Liabilities=Total Assets (A: Dec. 2021 )-Total Equity (A: Dec. 2021 )
=3.652-2.347
=1.31

RenovaCare's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.711+(0.8+3.4694469519536E-18
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.52

Total Liabilities=Total Assets (Q: Sep. 2022 )-Total Equity (Q: Sep. 2022 )
=1.055--1.46
=2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2.52 Mil mean?
RenovaCare (RCAR) has a Total Liabilities of $2.52 Mil as of Sep. 2022. The total amount of liabilities as recorded on a company's balance sheet. View historical data for RenovaCare and its competitors.
Is RenovaCare's Total Liabilities too high?
RenovaCare's current Total Liabilities is $2.52 Mil.
How does RenovaCare's Total Liabilities compare to ONCSQ and STAB?
RenovaCare's Total Liabilities of $2.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for RenovaCare and its competitors. RenovaCare's current Total Liabilities is $2.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RenovaCare stock overvalued right now?
RenovaCare (RCAR) has a current Total Liabilities of $2.52 Mil. The current Total Liabilities is $2.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For RenovaCare (RCAR), the current Total Liabilities is $2.52 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RenovaCare Business Description

Address 9375 East Shea Boulvard, Suite 107-A, Scottsdale, AZ, USA, 85260
RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.